Paper29344179
In vivo antitumor activity evaluation of cancer vaccines prepared by various antigen forms in a murine hepatocellular carcinoma model.
Si C and 7 others. Oncol Lett, 2017. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. In vivo antitumor activity evaluation of cancer vaccines prepared by various antigen forms in a murine hepatocellular carcinoma model. Papers, record 29344179. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29344179
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- In vivo antitumor activity evaluation of cancer vaccines prepared by various antigen forms in a murine hepatocellular carcinoma model.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References24
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20653081 | A novel therapeutic vaccine of GM-CSF/TNFalpha surface-modified RM-1 cells against the orthotopic prostatic cancer. | Vaccine | 2010 | https://conductscience.org/library/papers/20653081 | PubMed |
| 2 | 23428946 | Adjuvant GM-CSF improves survival in high-risk stage iiic melanoma: a single-center Study. | Am J Clin Oncol | 2014 | https://conductscience.org/library/papers/23428946 | PubMed |
| 3 | 21321245 | Vaccination with OK-432 followed by TC-1 tumor lysate leads to significant antitumor effects. | Reprod Sci | 2011 | https://conductscience.org/library/papers/21321245 | PubMed |
| 4 | 23456765 | Improved efficacy of therapeutic vaccination with viable human umbilical vein endothelial cells against murine melanoma by introduction of OK432 as adjuvant. | Tumour Biol | 2013 | https://conductscience.org/library/papers/23456765 | PubMed |
| 5 | 23261248 | Mechanical loading promotes mast cell degranulation via RGD-integrin dependent pathways. | J Biomech | 2013 | https://conductscience.org/library/papers/23261248 | PubMed |
| 6 | 25981111 | Specific cellular immune response elicited by the necrotic tumor cell-stimulated macrophages. | Int Immunopharmacol | 2015 | https://conductscience.org/library/papers/25981111 | PubMed |
| 7 | 17420942 | A phase I pilot study of autologous heat shock protein vaccine HSPPC-96 in patients with resected pancreatic adenocarcinoma. | Dig Dis Sci | 2007 | https://conductscience.org/library/papers/17420942 | PubMed |
| 8 | 24101126 | Intradermal immunization with combined baculovirus and tumor cell lysate induces effective antitumor immunity in mice. | Int J Oncol | 2013 | https://conductscience.org/library/papers/24101126 | PubMed |
| 9 | 17980936 | Preventive and therapeutic antitumor effect of tumor vaccine composed of CpG ODN class C and irradiated tumor cells is triggered through the APCs and activation of CTLs. | Vaccine | 2007 | https://conductscience.org/library/papers/17980936 | PubMed |
| 10 | 26221228 | The tumor protection effect of high-frequency administration of whole tumor cell vaccine and enhanced efficacy by the protein component from Agrocybe aegerita. | Int J Clin Exp Med | 2015 | https://conductscience.org/library/papers/26221228 | PubMed |
| 11 | 21761245 | Anti-tumor immune responses in immune-reconstituted mice injected with a tumor vaccine. | Med Oncol | 2012 | https://conductscience.org/library/papers/21761245 | PubMed |
| 12 | 20838433 | Strain-transcendent immune response to recombinant Var2CSA DBL5-ε domain block P. falciparum adhesion to placenta-derived BeWo cells under flow conditions. | PLoS One | 2010 | https://conductscience.org/library/papers/20838433 | PubMed |
| 13 | 22971679 | Phase I/II study of immunotherapy using tumor antigen-pulsed dendritic cells in patients with hepatocellular carcinoma. | Int J Oncol | 2012 | https://conductscience.org/library/papers/22971679 | PubMed |
| 14 | 19394651 | Anti-angiogenic therapy on hepatocellular carcinoma development and progression. | J Surg Res | 2010 | https://conductscience.org/library/papers/19394651 | PubMed |
| 15 | 10207881 | Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene. | Nat Biotechnol | 1999 | https://conductscience.org/library/papers/10207881 | PubMed |
| 16 | 14643445 | Protective antitumor immunity induced by fixed tumor cells in combination with adjuvant in a murine hepatoma model. | Cancer Lett | 2003 | https://conductscience.org/library/papers/14643445 | PubMed |
| 17 | 25310154 | Tumor cell lysate induces the immunosuppression and apoptosis of mouse immunocytes. | Mol Med Rep | 2014 | https://conductscience.org/library/papers/25310154 | PubMed |
| 18 | 17242926 | Prevention of human PC-346C prostate cancer growth in mice by a xenogeneic tissue vaccine. | Cancer Immunol Immunother | 2007 | https://conductscience.org/library/papers/17242926 | PubMed |
| 19 | 23528346 | Liver cancer: The promise of new approaches in the management of hepatocellular carcinoma--adding to the toolbox? | Nat Rev Gastroenterol Hepatol | 2013 | https://conductscience.org/library/papers/23528346 | PubMed |
| 20 | 24357284 | Breakthrough of the year 2013. Cancer immunotherapy. | Science | 2013 | https://conductscience.org/library/papers/24357284 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41810102 | Tumor Vaccines in Hepatocellular Carcinoma: Advances, Challenges, and the Path Toward Precision Immunotherapy. | J Clin Transl Hepatol | 2026 | https://conductscience.org/library/papers/41810102 | PubMed |
| 39853538 | Immunomodulatory activity of Trypanosoma cruzi recombinant antigen combination TSA-1-C4 and Tc24-C4 induce activation of macrophages and CD8+ T cells. | Parasitol Res | 2025 | https://conductscience.org/library/papers/39853538 | PubMed |
| 38206300 | Integrated multi-omics analyses reveal the TM4SF family genes with prognostic and therapeutic relevance in hepatocellular carcinoma. | Aging (Albany NY) | 2024 | https://conductscience.org/library/papers/38206300 | PubMed |
| 37631925 | A Comprehensive Review on Cancer Vaccines and Vaccine Strategies in Hepatocellular Carcinoma. | Vaccines (Basel) | 2023 | https://conductscience.org/library/papers/37631925 | PubMed |
| 35457221 | Changing Landscape of Cancer Vaccines-Novel Proteomics Platform for New Antigen Compositions. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35457221 | PubMed |
| 32899197 | Translational Considerations to Improve Response and Overcome Therapy Resistance in Immunotherapy for Hepatocellular Carcinoma. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32899197 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29344179
GET https://conductscience.org/api/papers/v1/29344179/references?page=2